Saint Roch Veterinary LLC unveils GingiGuard ™, a breakthrough, patented treatment for canine periodontitis with sustained plaque suppression.

Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug (IND) application to begin ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

“Our findings suggest that injectable hydrogels with localized anti-catabolic drug delivery can complement systemic ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...

Explore how systemic healthcare barriers and socioeconomic factors contribute to the alarming maternal mortality crisis ...

Osteoporosis is a disease in which bone resorbs faster than it is formed, gradually weakening its structure over time and ...

In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...

I left understanding why patients often distrust the medical system or leave hospitals against medical advice.” ...

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Roche's breast-cancer drug Itovebi in combination with two existing treatments doubles progression-free survival of patients, according to late-stage trial data.

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture ...